Pharmaceutical Passivation Services
Pharmaceutical Passivation Services refer to specialized chemical and mechanical treatments applied to stainless steel equipment and production surfaces in drug manufacturing facilities to remove free iron, contaminants, and surface impurities, thereby enhancing corrosion resistance, ensuring regulatory compliance, maintaining product purity, and supporting Good Manufacturing Practice standards across pharmaceutical production environments.

Passivation Reimagined: Outsourcing Integrity in the Age of Complex Formulations
In pharmaceutical manufacturing, the integrity of production equipment is not merely a matter of operational efficiency but a cornerstone of product safety and efficacy. Central to this is the practice of passivation, a critical chemical process that enhances the corrosion resistance of stainless-steel surfaces, the ubiquitous material of choice for manufacturing vessels, piping, and other vital components. Traditionally an in-house activity, passivation is increasingly being externalized through a "Passivation as a Service" (PaaS) model. This strategic shift is fundamentally reshaping how pharmaceutical companies approach facility lifecycle management, driven by the rise of specialized vendors and the logistical prowess of mobile service units, particularly in supporting multi-site operations.

The market demand for large-scale cell culture production capacity is growing, and FUJIFILM Diosynth Biotechnologies is meeting the market demand by expanding its production capacity with new drug substances, drug products, and finished goods facilities. And we are deploying a modular approach specifically for drug substance manufacturing.
